======= ASH2L =======
== Gene Information ==
* **Official Symbol**: ASH2L
* **Official Name**: ASH2 like, histone lysine methyltransferase complex subunit
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9070|9070]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBL3|Q9UBL3]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ASH2L&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ASH2L|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604782|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Component of the Set1/Ash2 histone methyltransferase (HMT) complex, a complex that specifically methylates 'Lys-4' of histone H3, but not if the neighboring 'Lys-9' residue is already methylated. As part of the MLL1/MLL complex it is involved in methylation and dimethylation at 'Lys-4' of histone H3. May function as a transcriptional regulator. May play a role in hematopoiesis. {ECO:0000269|PubMed:12670868, ECO:0000269|PubMed:19556245}.
|SPRY|
|euchromatin binding|
|Set1C/COMPASS complex|
|MLL3/4 complex|
|histone methyltransferase activity (H3-K4 specific)|
|beta-catenin-TCF complex assembly|
|MLL1 complex|
|nuclear euchromatin|
|histone H3-K4 methylation|
|histone methyltransferase complex|
|regulation of megakaryocyte differentiation|
|histone lysine methylation|
|response to estrogen|
|beta-catenin binding|
|peptidyl-lysine methylation|
|histone methylation|
|protein methylation|
|protein alkylation|
|transcription regulatory region DNA binding|
|regulation of myeloid cell differentiation|
|macromolecule methylation|
|methylation|
|peptidyl-lysine modification|
|histone modification|
|covalent chromatin modification|
|regulation of hemopoiesis|
|hemopoiesis|
|hematopoietic or lymphoid organ development|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|immune system development|
|RNA biosynthetic process|
|chromatin organization|
|cellular response to DNA damage stimulus|
|peptidyl-amino acid modification|
|positive regulation of cell population proliferation|
|chromosome organization|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|positive regulation of transcription by RNA polymerase II|
|organic cyclic compound biosynthetic process|
|positive regulation of transcription, DNA-templated|
|protein-containing complex assembly|
|regulation of cell population proliferation|
|cellular nitrogen compound biosynthetic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|regulation of immune system process|
|RNA metabolic process|
|cellular response to stress|
|cellular macromolecule biosynthetic process|
|positive regulation of RNA metabolic process|
|macromolecule biosynthetic process|
|regulation of cell differentiation|
|protein-containing complex subunit organization|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp244|SB743921 0.001μM R05 exp244]]|-2.07|
|[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|-1.95|
|[[:results:exp61|YM155 0.0002μM R01 exp61]]|-1.9|
|[[:results:exp532|TIC10 10μM R08 exp532]]|-1.81|
|[[:results:exp464|Calcipotriol 5μM R08 exp464]]|1.72|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1130
* **Expression level (log2 read counts)**: 6.05
{{:chemogenomics:nalm6 dist.png?nolink |}}